Outcomes of Carbapenem-Resistant  Klebsiella pneumoniae  Infection and the Impact of Antimicrobial and Adjunctive Therapies

Patel, Gopi; Huprikar, Shirish; Factor, Stephanie H.; Jenkins, Stephen G.; Calfee, David P.

doi:10.1086/592412

articleInfection Control and Hospital EpidemiologyOct 30, 2008Closed access

Outcomes of Carbapenem-Resistant Klebsiella pneumoniae Infection and the Impact of Antimicrobial and Adjunctive Therapies

GPGopi Patel SHShirish Huprikar SHStephanie H. Factor SGStephen G. Jenkins DPDavid P. Calfee

Icahn School of Medicine at Mount Sinai

PubMed

Indexed incrossrefpubmed

Abstract

Background

Carbapenem-resistant Klebsiella pneumoniae is an emerging healthcare-associated pathogen.

Objective

To describe the epidemiology of and clinical outcomes associated with carbapenem-resistant K. pneumoniae infection and to identify risk factors associated with mortality among patients with this type of infection.

Citation impact

836

total citations

FWCI: 9.56
Percentile: 100%
References: 28

Citations per year

Authors

5

Topics & keywords

Topics

Keywords

Klebsiella pneumoniae
Medicine
Carbapenem
Infection control
Internal medicine
Antibiotics
Antimicrobial
Carbapenem-resistant enterobacteriaceae

UN Sustainable Development Goals

Good health and well-being

No related works found for this paper.